NEW YORK – Top health officials from the Trump administration, including US Department of Health & Human Services Secretary Robert F. Kennedy Jr. and US Food and Drug Administration Commissioner Marty ...

2025 Biopharma Industry Outlook: Growth, Innovation, and Emerging Risks Innovations in obesity, oncology, immunology, and AI are shaping biopharma’s future and investment opportunities.

How 3PL providers are gearing up for the wave of cell and gene therapies 3PL logistics need to invest in new technology and upskilling programs to scale their CGT services in line with projected ...

Kevin Chinn, Vice President, Cell & Gene Therapy at Cencora, remarked on this partnership, saying, “We believe in the promise of cell and gene therapies and are committed to providing CGT developers ...

Kevin Chinn, Vice President, Cell & Gene Therapy at Cencora remarked on this partnership, saying, “We believe in the promise of cell and gene therapies and are committed to providing CGT developers ...

Each year, the ESGCT conference attracts key opinion leaders in gene and cell therapy from Europe and around the world, spotlighting recent breakthroughs and advancements in the field and ...

Retail pharmacy chains such as Walgreens and CVS have pivoted from years of endless store expansions to shuttering hundreds of locations across the U.S. to shore up profits. Among the biggest ...

Cencora, Inc. (NYSE:COR) Q3 2024 Earnings Conference Call July 31, 2024 8:30 AM ETCompany ParticipantsBennett Murphy - Senior Vice President, Head of ...

The firm announced a move to strengthen its core pharmacy business in April, detailing plans to deepen its specialty pharmacy offerings to include cell and gene therapy services.